Doc Go Inc. DCGO
We take great care to ensure that the data presented and summarized in this overview for DocGo Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding DCGO
View all-
Deerfield Management Company, L.P. (Series C) New York, NY9.07MShares$38.9 Million0.56% of portfolio
-
Black Rock Inc. New York, NY7.04MShares$30.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5MShares$21.4 Million0.0% of portfolio
-
Knott David M Jr Syosset, NY3.07MShares$13.2 Million3.58% of portfolio
-
Wcm Investment Management, LLC Laguna Beach, CA2.63MShares$11.3 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA2.25MShares$9.66 Million0.0% of portfolio
-
State Street Corp Boston, MA1.93MShares$8.28 Million0.0% of portfolio
-
Punch & Associates Investment Management, Inc. Edina, MN1.67MShares$7.15 Million0.33% of portfolio
-
S Squared Technology, LLC New York, NY1.64MShares$7.02 Million2.32% of portfolio
-
P.A.W. Capital Corp1.63MShares$6.99 Million12.22% of portfolio
Latest Institutional Activity in DCGO
Top Purchases
Top Sells
About DCGO
DocGo, Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home and offices; COVID-19 testing; and event services, which include on-site healthcare support at sporting events and concerts. DocGo, Inc. was incorporated in 2015 and is headquartered in New York, New York.
Insider Transactions at DCGO
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 17
2024
|
Etalvina Leite Director |
SELL
Open market or private sale
|
Direct |
16,500
-24.3%
|
$66,000
$4.34 P/Share
|
Dec 16
2024
|
Ely D Tendler General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
23,088
-11.62%
|
$92,352
$4.44 P/Share
|
Dec 13
2024
|
Etalvina Leite Director |
BUY
Grant, award, or other acquisition
|
Direct |
34,965
+33.99%
|
-
|
Dec 13
2024
|
James M Travers Director |
BUY
Grant, award, or other acquisition
|
Direct |
34,965
+27.76%
|
-
|
Dec 13
2024
|
Ira Smedra Director |
BUY
Grant, award, or other acquisition
|
Direct |
34,965
+27.76%
|
-
|
Dec 13
2024
|
Michael J Burdiek Director |
BUY
Grant, award, or other acquisition
|
Direct |
34,965
+5.37%
|
-
|
Dec 13
2024
|
Stephen Sugrue Chief Compliance Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,734
-2.94%
|
$34,936
$4.19 P/Share
|
Dec 13
2024
|
Norman Rosenberg CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
19,213
-2.61%
|
$76,852
$4.19 P/Share
|
Dec 13
2024
|
Lee Bienstock Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
86,236
-5.1%
|
$344,944
$4.19 P/Share
|
Dec 12
2024
|
Ely D Tendler General Counsel and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
35,800
+15.26%
|
-
|
Dec 12
2024
|
Stephen Sugrue Chief Compliance Officer |
BUY
Grant, award, or other acquisition
|
Direct |
107,399
+26.58%
|
-
|
Dec 12
2024
|
Norman Rosenberg CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
346,062
+31.94%
|
-
|
Dec 12
2024
|
Lee Bienstock Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
536,993
+24.09%
|
-
|
Oct 04
2024
|
Norman Rosenberg CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,004
-2.04%
|
$24,012
$3.35 P/Share
|
Oct 04
2024
|
Stephen Sugrue Chief Compliance Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,104
-2.17%
|
$12,312
$3.35 P/Share
|
Oct 04
2024
|
Lee Bienstock Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
18,598
-1.61%
|
$55,794
$3.35 P/Share
|
Jul 09
2024
|
Lee Bienstock Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
18,598
-1.58%
|
$37,196
$2.93 P/Share
|
Jul 09
2024
|
Norman Rosenberg CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,004
-2.0%
|
$16,008
$2.93 P/Share
|
Jul 09
2024
|
Stephen Sugrue Chief Compliance Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,104
-2.12%
|
$8,208
$2.93 P/Share
|
Jun 21
2024
|
Lee Bienstock Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,194
-1.11%
|
$52,776
$4.04 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 1.61M shares |
---|---|
Open market or private purchase | 78.5K shares |
Payment of exercise price or tax liability | 238K shares |
---|---|
Open market or private sale | 39.6K shares |